C3d Activators comprise a specialized set of chemicals that target the modulation of C3d, a fragment found in the proteolytic cleavage of the complement component C3, which is a central protein in the complement system of the innate immune response. C3d is known for its role in opsonization, which enhances the phagocytosis of pathogens, and in modulating adaptive immune responses by binding to complement receptor 2 (CR2) on B cells.
Activators of C3d typically function by influencing the complement cascade that leads to the generation of C3d from its precursor, C3. Direct activators may interact with the enzymes responsible for the cleavage of C3, such as complement factor I and factor H, thereby promoting the formation of more C3d. These chemicals might also stabilize C3d or enhance its interaction with CR2, thus potentiating its immunomodulatory effects. Indirect C3d activators might upregulate the complement pathway by promoting the expression of C3 or by inhibiting the degradation of C3 convertase, the enzyme complex that cleaves C3 into C3a and C3b, the latter of which is further processed into C3d. These activators could also affect the regulation of complement inhibitors, thereby indirectly leading to increased C3d activity. The role of C3d in immune responses is a significant research focus, as it represents a crucial link between the innate and adaptive arms of the immune system. Investigating C3d Activators can provide insights into the regulation of immune responses and the mechanisms by which the complement system influences various immunological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS (lipopolysaccharide) is known to trigger the complement pathway, which C3d is a part of. LPS activates the alternative pathway of the complement system, leading to the cleavage of C3 to C3b and C3d. | ||||||
Zymosan A from Saccharomyces cerevisiae | 58856-93-2 | sc-258367 sc-258367A | 250 mg 1 g | $90.00 $222.00 | 2 | |
Zymosan is a polysaccharide found in yeast cell walls. It can activate the alternative pathway of the complement system, leading to the cleavage of C3 into C3b and C3d. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Cobalt Chloride is a chemical compound that can induce hypoxia-like conditions. Hypoxia can lead to the activation of the alternative complement pathway, enhancing the generation of C3d. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A, a plant lectin, can induce the activation of the lectin pathway of the complement system, leading to the cleavage of C3 into C3b and C3d. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and a potent tumor promoter often used in biomedical research to activate the signal transduction enzyme, protein kinase C. Activation of PKC can lead to cell stimulation and the release of C3 convertase, enhancing the cleavage of C3 to C3b and C3d. | ||||||